Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2001

01-05-2001

Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer

Authors: Masaru Ooka, Yasuhiro Tamaki, Isao Sakita, Yoshiyuki Fujiwara, Hirofumi Yamamoto, Yasuhiro Miyake, Mitsugu Sekimoto, Masayuki Ohue, Yurika Sugita, Yasuo Miyoshi, Noriko Ikeda, Shinzaburo Noguchi, Morito Monden

Published in: Breast Cancer Research and Treatment | Issue 2/2001

Login to get access
Metadata
Title
Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer
Authors
Masaru Ooka
Yasuhiro Tamaki
Isao Sakita
Yoshiyuki Fujiwara
Hirofumi Yamamoto
Yasuhiro Miyake
Mitsugu Sekimoto
Masayuki Ohue
Yurika Sugita
Yasuo Miyoshi
Noriko Ikeda
Shinzaburo Noguchi
Morito Monden
Publication date
01-05-2001
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/2001
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1010651632354

Other articles of this Issue 2/2001

Breast Cancer Research and Treatment 2/2001 Go to the issue

OriginalPaper

The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonography

OriginalPaper

Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue

OriginalPaper

Impact of the axillary nodal status on sentinel node mapping in breast cancer and its relevance for technical proceeding

Letter to the Editor

Letter to the editor

OriginalPaper

Suppression of aromatase (estrogen synthetase) by red wine phytochemicals

Instructions for Authors

Breast Cancer Research and Treatment
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits